Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 474 | 531 | 0 | 0 | 0 |
| Gross Profit | 474 | 531 | N/A | N/A | N/A |
| Operating Expenses | 1,039 | 1,743 | 1,565 | 3,123 | 8,326 |
| Operating Income | -565 | -1,212 | -1,565 | -3,123 | -8,326 |
| Interest Expense | 455 | 435 | 1,839 | 2,644 | 2,523 |
| Other Income | 78 | 1 | 521 | 6,279 | 72 |
| Pre-tax Income | -942 | -1,646 | -2,882 | 512 | -10,777 |
| Net Income Continuous | -942 | -1,646 | -2,882 | 512 | -10,777 |
| Net Income | $-942 | $-1,646 | $-2,882 | $512 | $-10,777 |
| EPS Basic Total Ops | -150.00 | -300.00 | -500.00 | 50.00 | -2,300.00 |
| EPS Basic Continuous Ops | -153.66 | -268.55 | -486.43 | 96.01 | -2,306.61 |
| EPS Diluted Total Ops | -150.00 | -300.00 | -500.00 | 0.00 | -2,300.00 |
| EPS Diluted Continuous Ops | -153.66 | -268.55 | -486.43 | 81.11 | -2,306.61 |
| EPS Diluted Before Non-Recurring Items | -150.00 | -300.00 | -500.00 | N/A | N/A |
| EBITDA(a) | $-564 | $-1,211 | $-1,517 | $-3,046 | $-8,254 |